May 23, 2023
Congratulations to affiliate faculty member Dr. Da Ma on his latest publication, "Safety, tolerability, and effectiveness of the sodium-glucose cotransporter 2 inhibitor (SGLT2i) dapagliflozin in combination with standard chemotherapy for patients with advanced, inoperable pancreatic adenocarcinoma: a phase 1b observational study" published in Cancer & Metabolism. Dr. Ma is a member in Subcluster 2: Brain Imaging and Artificial Intelligence and Subcluster 4: Ophthalmic Imaging for Eye and Brain Disease in the Vision Research Cluster.